Please wait while we open this resource.
K
Clinical reviews
GLICLAZIDE IN TYPE 2 DIABETES: COST-EFFECTIVE AND CLINICALLY RELEVANT IN RESOURCE-LIMITED SETTINGS
Dr. Reddy
PDF2 pages308 KB
Gliclazide remains a preferred option among sulfonylureas for managing type 2 diabetes due to its proven efficacy and safety profile. The document reviews evidence from various studies, including the ADVANCE trial, which supports gliclazide's glycemic control and microvascular benefits. It also addresses the pharmacologic selectivity of gliclazide and its implications for clinical practice, emphasizing the need for further pharmacoeconomic research to validate its relevance in real-world diabetes care.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
ADA Consensus Report: MASLD in People With Diabetes
Same clinical topic · Endocrinology
2025 ADA Diabetes Care Standards Updates
Same clinical topic · Endocrinology
METFORMIN―MECHANISMS OF ITS GLYCEMIA-REDUCING EFFECT
Same clinical topic · Endocrinology
SYNDROME OF INAPPROPRIATE ANTIDIURESIS: FROM PATHOPHYSIOLOGY TO MANAGEMENT
Same clinical topic · Endocrinology
GLYCEMIC EMERGENCIES
Same clinical topic · Endocrinology
DIAGNOSIS AND MANAGEMENT OF CENTRAL DIABETES INSIPIDUS IN ADULTS
Same clinical topic · Endocrinology
ANTI-OBESITY DRUGS: COMPREHENSIVE REVIEW AND EMERGING THERAPIES
Same clinical topic · Endocrinology
DRUG DELIVERY SYSTEMS FOR THYROID DISEASE TREATMENT: A MINI REVIEW ON CURRENT THERAPIES AND ALTERNATIVE APPROACHES
Same clinical topic · Endocrinology
OTHER BENEFITS OF CONTROLLING CARBOHYDRATES
Same clinical topic · Endocrinology